Distillery Therapeutics


<div class="articleContainer">
<div class="articleWrapper">
<div class="articleContent">
<h1 class="text title distillery_title" doc-editable="text" data-component-id="doc-1ef7l992d0">Combining ULK1, ULK2 inhibition with anti-PD-1 therapy in NSCLC&#xa0;&#xa0;</h1><div class="byline ng-tns-c17-4 ng-star-inserted" data-component-id="doc-1ef7l9he70">
    <span class="ng-tns-c17-4" doc-editable="text">By Claire Quang, Staff Writer</span>
</div><div class="date" data-component-id="doc-1ef7l9jmf0">
  <span class="byline" doc-editable="text"></span>
</div></div></div></div>


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

New York University Langone Medical Center

DISEASE CATEGORY: CancerINDICATION: Lung cancer......

Cancer

Lung cancer

unc-51 like autophagy activating kinase 1 (ULK1)

Unc-51 like autophagy activating kinase 2 (ULK2) (ATG1B)

Serine/threonine kinase 11 (STK11) (LKB1)

Combining ULK1, ULK2 inhibition with anti-PD-1 therapy in NSCLC  

DISEASE CATEGORY: Cancer<br/>INDICATION: Lung cancer Inhibiting ULK1 and ULK2, which regulate autophagy, could increase the sensitivity of anti-PD-1 therapy in STK11-mutant non-small cell lung cancer

Featured Analysis

Articles by Category

Current Editions

Data Graphics

Discovery & Translation Analysis

Discovery & Translation

Hot Topics

BioCentury Podcasts 

Special Reports & Presentations

White Papers

Analysis

BCIQ

Company Profiles

Product Profiles

Target Profiles

Financial Dashboards

BCIQ Data Coverage

BCIQ Data

All Events

BioCentury's JPM Guide 2026

JPM Guide 2026

East-West Healthcare Reception

At the East-West Summit, you will meet key players looking to globalize innovation from across Asia.